Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363,214,619
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
118,779,098
-
Shares change
-
-1,219,502
-
Total reported value, excl. options
-
$220,940,693
-
Value change
-
-$2,430,736
-
Put/Call ratio
-
47%
-
Number of buys
-
33
-
Number of sells
-
-47
-
Price
-
$1.86
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2022
103 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2022.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118,779,098 shares
of 363,214,619 outstanding shares and own 33% of the company stock.
Largest 10 shareholders include Artal Group S.A. (71,178,364 shares), BVF INC/IL (14,149,179 shares), FMR LLC (5,290,601 shares), BlackRock Inc. (4,519,829 shares), VANGUARD GROUP INC (3,921,970 shares), D. E. Shaw & Co., Inc. (3,228,072 shares), NEA Management Company, LLC (2,382,286 shares), PINNACLE ASSOCIATES LTD (2,087,463 shares), STATE STREET CORP (1,352,001 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,341,413 shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.